Literature DB >> 1895490

Use of albumin as a volume expander.

J P Doweiko1, D J Nompleggi.   

Abstract

In some hospitals, albumin products account for 10% of the pharmaceutical budget. As much as 60% of these prescriptions are empiric, and from 40 to 70% of albumin that is administered is given for inappropriate reasons. Although the reasons for albumin administration vary, prevention or reversal of hypovolemia is part of the reason in the majority of cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1895490     DOI: 10.1177/0148607191015004484

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  4 in total

1.  The prognostic value of the nutritional prognostic index (NPI) and controlling nutritional status (CONUT) scoring systems in non-ST elevated myocardial infarction patients over 65 years of age.

Authors:  Bedrettin Boyraz; Ersin Ibisoglu; Burhan Aslan
Journal:  Aging Clin Exp Res       Date:  2022-01-07       Impact factor: 3.636

2.  Evaluation of human albumin use in a university hospital in Belgium.

Authors:  A Somers; T Bauters; H Robays; M Bogaert; F Colardyn
Journal:  Pharm World Sci       Date:  2002-06

Review 3.  Debate: Albumin administration should be avoided in the critically ill.

Authors:  T B Pulimood; G R Park
Journal:  Crit Care       Date:  2000       Impact factor: 9.097

Review 4.  Review of the rational use and adverse reactions to human serum albumin in the People's Republic of China.

Authors:  Ting Zhou; Saihua Lu; Xiufeng Liu; Ye Zhang; Feng Xu
Journal:  Patient Prefer Adherence       Date:  2013-11-28       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.